<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Pharmacodynamics on Mycobacterial Infection Research Unit</title>
    <link>https://miru-ffm.org/tags/pharmacodynamics/</link>
    <description>Recent content in Pharmacodynamics on Mycobacterial Infection Research Unit</description>
    <generator>Source Themes academia (https://sourcethemes.com/academic/)</generator>
    <language>en-us</language>
    <copyright>Copyright &amp;copy; {year}</copyright>
    
	    <atom:link href="https://miru-ffm.org/tags/pharmacodynamics/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>LEVEL-UP-TB</title>
      <link>https://miru-ffm.org/project/leveluptb/</link>
      <pubDate>Mon, 01 Jan 0001 00:00:00 +0000</pubDate>
      
      <guid>https://miru-ffm.org/project/leveluptb/</guid>
      <description>&lt;p&gt;Tuberculosis therapy is usuallay administered in weight adapted doses. However, factors like fast-metabolizing enzymes, malabsorption, and drug interactions can influence their serum drug levels. This is not yet taken into account as part of the clinical routine or therapeutic guidelines.&lt;br&gt;
&lt;br&gt;
&lt;br&gt;
The LEVEL-UP-TB project evaluates different factors predicting serum drug levels of antimycobacterial therapy as well as their influence on therapeutic outcome.
&lt;br&gt;
&lt;br&gt;
&lt;a href=&#34;https://miru-ffm.org/#contact&#34;&gt;Contact PI&lt;/a&gt;&lt;/p&gt;
</description>
    </item>
    
  </channel>
</rss>
